Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
NL0011832936
Wed, 28.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Product Launch
Cosmo announces Cortiment® approval in Japan
28.06.2023 / 06:15 GMT/BST
Dublin, Ireland – 28 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its partner Ferring Pharmaceuticals (“Ferring”) has received the ap [ … ]
Thu, 22.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Agreement
Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea
22.06.2023 / 06:15 GMT/BST
Dublin, Ireland & Seoul, Korea – 22 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Hyundai Pharmaceutical Co., Ltd [ … ]
Thu, 22.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Agreement
Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea
22.06.2023 / 06:15 GMT/BST
Dublin, Ireland & Seoul, Korea – 22 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Hyundai Pharmaceutical Co., Ltd [ … ]
Tue, 20.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Regulatory Approval
Cosmo Pharmaceuticals announces approval of Winlevi® in Canada
20.06.2023 / 06:15 GMT/BST
Dublin, Ireland – 20 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its partner Sun Pharmaceutical Industries Limited (Reuters: SUN.B [ … ]
Tue, 20.06.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Regulatory Approval
Cosmo Pharmaceuticals announces approval of Winlevi® in Canada
20.06.2023 / 06:15 GMT/BST
Dublin, Ireland – 20 June 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its partner Sun Pharmaceutical Industries Limited (Reuters: SUN.B [ … ]
Fri, 26.05.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): AGMEGM
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting
26.05.2023 / 16:30 GMT/BST
Dublin, Ireland – 26 May 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its shareholders approved all agenda items at today's a [ … ]
Fri, 26.05.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): AGMEGM
Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting
26.05.2023 / 16:30 GMT/BST
Dublin, Ireland – 26 May 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced that its shareholders approved all agenda items at today's a [ … ]
Thu, 30.03.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Agreement
Cosmo announces territory expansion agreement for Lumeblue™ (Methylene Blue MMX™) with China Medical System Holdings
30.03.2023 / 06:00 GMT/BST
Dublin, Ireland – March 30, 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced the territory expansio [ … ]
Thu, 30.03.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Agreement
Cosmo announces territory expansion agreement for Lumeblue™ (Methylene Blue MMX™) with China Medical System Holdings
30.03.2023 / 06:00 GMT/BST
Dublin, Ireland – March 30, 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced the territory expansio [ … ]
Thu, 16.03.2023
Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V.
/ Key word(s): Annual Results
Invitation to Cosmo’s full-year 2022 financial results and 2023 outlook webcast presentation on 23 March 2023
16.03.2023 / 06:00 GMT/BST
Dublin, Ireland – 16 March 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) announced today that it will publish its [ … ]